Amplia Therapeutics Statistics
Total Valuation
INNMF has a market cap or net worth of 75.10 million. The enterprise value is 68.00 million.
Market Cap | 75.10M |
Enterprise Value | 68.00M |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
Earnings Date | Aug 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 387.95M |
Shares Outstanding | n/a |
Shares Change (YoY) | +58.35% |
Shares Change (QoQ) | +42.19% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 258.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 31.83 |
PB Ratio | 5.73 |
P/TBV Ratio | 9.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -16.59 |
EV / Sales | 27.44 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -15.83 |
Financial Position
The company has a current ratio of 7.91, with a Debt / Equity ratio of 0.00.
Current Ratio | 7.91 |
Quick Ratio | 7.75 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | -0.00 |
Interest Coverage | -121.54 |
Financial Efficiency
Return on equity (ROE) is -40.51% and return on invested capital (ROIC) is -24.94%.
Return on Equity (ROE) | -40.51% |
Return on Assets (ROA) | -22.47% |
Return on Invested Capital (ROIC) | -24.94% |
Return on Capital Employed (ROCE) | -32.27% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.20 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +210.13% in the last 52 weeks. The beta is 0.38, so INNMF's price volatility has been lower than the market average.
Beta (5Y) | 0.38 |
52-Week Price Change | +210.13% |
50-Day Moving Average | 0.06 |
200-Day Moving Average | 0.06 |
Relative Strength Index (RSI) | 70.06 |
Average Volume (20 Days) | 17,551 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, INNMF had revenue of 2.36 million and -4.10 million in losses. Loss per share was -0.01.
Revenue | 2.36M |
Gross Profit | 2.23M |
Operating Income | -4.24M |
Pretax Income | -4.10M |
Net Income | -4.10M |
EBITDA | -4.23M |
EBIT | -4.24M |
Loss Per Share | -0.01 |
Balance Sheet
The company has 6.78 million in cash and 8,665 in debt, giving a net cash position of 6.77 million.
Cash & Cash Equivalents | 6.78M |
Total Debt | 8,665 |
Net Cash | 6.77M |
Net Cash Per Share | n/a |
Equity (Book Value) | 13.11M |
Book Value Per Share | 0.03 |
Working Capital | 8.13M |
Cash Flow
In the last 12 months, operating cash flow was -4.29 million and capital expenditures -1,292, giving a free cash flow of -4.30 million.
Operating Cash Flow | -4.29M |
Capital Expenditures | -1,292 |
Free Cash Flow | -4.30M |
FCF Per Share | n/a |
Margins
Gross margin is 94.43%, with operating and profit margins of -179.51% and -173.69%.
Gross Margin | 94.43% |
Operating Margin | -179.51% |
Pretax Margin | -173.69% |
Profit Margin | -173.69% |
EBITDA Margin | -179.24% |
EBIT Margin | -179.51% |
FCF Margin | n/a |
Dividends & Yields
INNMF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -58.35% |
Shareholder Yield | n/a |
Earnings Yield | -5.46% |
FCF Yield | -5.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
INNMF has an Altman Z-Score of -0.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.27 |
Piotroski F-Score | 2 |